PubRank

P Martásek

Author PubWeight™ 41.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 1998 4.94
2 Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998 3.20
3 Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 1999 1.49
4 Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications. FEBS Lett 2000 1.29
5 The C termini of constitutive nitric-oxide synthases control electron flow through the flavin and heme domains and affect modulation by calmodulin. J Biol Chem 2000 1.20
6 Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic Biol Med 2001 1.15
7 Involvement of the reductase domain of neuronal nitric oxide synthase in superoxide anion production. Biochemistry 1997 1.11
8 Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. J Med Chem 2001 1.09
9 Porphyrinogens in urine in various types of porphyrias. J Clin Chem Clin Biochem 1982 1.08
10 Recruitment of governing elements for electron transfer in the nitric oxide synthase family. Proc Natl Acad Sci U S A 2005 1.06
11 Homozygous variegate porphyria. Lancet 1984 0.99
12 Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases. J Med Chem 2000 0.96
13 Rapid kinetic studies of electron transfer in the three isoforms of nitric oxide synthase. Biochem Biophys Res Commun 1999 0.96
14 Cardiac involvement in Wilson disease. J Inherit Metab Dis 2002 0.94
15 Zinc content of Escherichia coli-expressed constitutive isoforms of nitric-oxide synthase. Enzymatic activity and effect of pterin. J Biol Chem 1999 0.94
16 Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 2001 0.93
17 Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors. Biochemistry 2001 0.93
18 Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration. Ann Med 1989 0.90
19 Electron spin resonance spin-trapping detection of superoxide generated by neuronal nitric oxide synthase. Methods Enzymol 1999 0.89
20 Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase. J Biol Chem 2001 0.88
21 Increased erythrocyte protoporphyrin in homozygous variegate porphyria. Photodermatol 1985 0.87
22 Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism. Biochemistry 2001 0.86
23 Kinetics of NO ligation with nitric-oxide synthase by flash photolysis and stopped-flow spectrophotometry. J Biol Chem 1999 0.85
24 Porphyrinogens in plasma. Arch Dermatol 1982 0.85
25 Kinetics of CO ligation with nitric-oxide synthase by flash photolysis and stopped-flow spectrophotometry. J Biol Chem 1997 0.84
26 Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas. J Inorg Biochem 2000 0.83
27 Haem arginate in acute hepatic porphyrias. Br Med J (Clin Res Ed) 1986 0.82
28 Synthesis and evaluation of dipeptide amides containing N omega-nitroarginine and D-2,4-diaminobutyric acids as inhibitors of neuronal nitric oxide synthase. J Enzyme Inhib 2001 0.81
29 Kinetics of CO and NO ligation with the Cys(331)-->Ala mutant of neuronal nitric-oxide synthase. J Biol Chem 2000 0.80
30 Effect of redox-active drugs on superoxide generation from nitric oxide synthases: biological and toxicological implications. Free Radic Res 1999 0.79
31 Structural basis for pterin antagonism in nitric-oxide synthase. Development of novel 4-oxo-pteridine antagonists of (6R)-5,6,7,8-tetrahydrobiopterin. J Biol Chem 2001 0.79
32 Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment. Semin Hematol 1989 0.79
33 Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosis. Folia Biol (Praha) 2011 0.77
34 Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis. Folia Biol (Praha) 2012 0.77
35 [Nitric oxide synthase, typical flavohemoproteins and their complicated enzymology]. Cas Lek Cesk 2006 0.76
36 [Primary biliary cirrhosis--specific anti-mitochondrial antibodies]. Vnitr Lek 2004 0.75
37 Haemoperfusion in acute intermittent porphyria. Br Med J (Clin Res Ed) 1984 0.75
38 [Antley-Bixler syndrome or POR deficiency?]. Cas Lek Cesk 2008 0.75
39 [The effect of chloroquine therapy on the level of porphyrins in the liver in symptomatic hepatic porphyria]. Cesk Gastroenterol Vyz 1982 0.75
40 RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining. Transl Psychiatry 2017 0.75
41 [Acute liver porphyria--hereditary coproporphyria diagnosed for the first time in Czechoslovakia]. Vnitr Lek 1985 0.75
42 [Familial adenomatous polyposis coli in the Czech population. I. Detection of an additional 3 mutations out of a total of 7 in exon 15 of the APC gene]. Cas Lek Cesk 1997 0.75
43 [Analysis of the most frequent mutations in girls with Rett syndrome]. Cas Lek Cesk 2001 0.75
44 [2 years' experience with the treatment of symptomatic liver porphyria with pyrimethamine]. Cas Lek Cesk 1985 0.75
45 [The effect of heme arginate (Normosang Leiras--Medica) on hemostasis]. Cas Lek Cesk 1988 0.75
46 [Porphyria variegata with clinical manifestations in the first days of life]. Cesk Pediatr 1985 0.75
47 [Congenital disorder of type Ia protein glycosylation: clinical, biochemical and molecular characteristics in 2 siblings with cerebellar hypoplasia]. Cas Lek Cesk 2003 0.75
48 [Treatment of acute intermittent porphyria. The first use of Heme-arginate in Czechoslovakia]. Cas Lek Cesk 1987 0.75
49 Porphyrins and porphyrinogens--clinical importance and polarographic behaviour. Acta Univ Carol Med (Praha) 1984 0.75
50 A new mutation within the porphobilinogen deaminase gene leading to a truncated protein as a cause of acute intermittent porphyria in an extended Indian family. Folia Biol (Praha) 2007 0.75
51 [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)]. Cas Lek Cesk 1981 0.75
52 [Diurnal rhythm of exertion of various types of porphyrins in symptomatic hepatic porphyria (author's transl)]. Cas Lek Cesk 1981 0.75
53 [Symptomatic liver porphyria with a familial incidence]. Cas Lek Cesk 1985 0.75
54 1H-pyrazole-1-carboxamidines: new inhibitors of nitric oxide synthase. Bioorg Med Chem Lett 2000 0.75
55 Substrate and substrate analog binding to endothelial nitric oxide synthase: electron paramagnetic resonance as an isoform-specific probe of the binding mode of substrate analogs. Biochemistry 1997 0.75
56 [The use of nitric oxide in the treatment of acute respiratory failure]. Cas Lek Cesk 2006 0.75
57 Variegate porphyria and porphyria cutanea tarda. Arch Dermatol 1983 0.75
58 Resin hemoperfusion in hepatic porphyrias. Artif Organs 1985 0.75
59 [Effect of pyrimethamine on clinical and biochemical manifestations of symptomatic liver porphyria]. Cas Lek Cesk 1983 0.75
60 [Rett syndrome: clinical and molecular aspects]. Cas Lek Cesk 2007 0.75
61 [Direct fluorometry of porphyrins. Significance for clinical practice and the etiology of porphyrias]. Cas Lek Cesk 1983 0.75
62 Striking antitumor activity of a methinium system with incorporated quinoxaline unit obtained by spontaneous cyclization. Chembiochem 2015 0.75
63 [Wilson's disease]. Cas Lek Cesk 2009 0.75
64 [Lead poisoning in an infant]. Cesk Pediatr 1986 0.75
65 Solid phase extraction and isocratic separation of urinary porphyrins by HPLC. Biomed Chromatogr 1986 0.75
66 Quo vadis porphyrin chemistry? Physiol Res 2006 0.75
67 [A new model for testing substances affecting the synthesis of heme]. Sb Lek 1989 0.75
68 Role of the kidneys in porphyrias. Nephron 1982 0.75
69 [Experience with the therapy of symptomatic liver porphyria using a combination of antimalarial agents--chloroquine with pyrimethamine]. Cas Lek Cesk 1987 0.75
70 Recovery from a severe attack of acute intermittent porphyria during coated-resin hemoperfusion. Int J Artif Organs 1986 0.75
71 [Acute liver porphyrias. I. Clinical and biochemical findings in 45 patients (1981-1982)]. Cas Lek Cesk 1984 0.75